Lexaria Bioscience (LEXX) Gross Profit (QoQ) (2017 - 2025)
Lexaria Bioscience (LEXX) Gross Profit (QoQ) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Lexaria Bioscience |
7.63 Mn |
2.11 Mn |
20,000.00 |
| Date | Value |
|---|
| Aug 31, 2025 |
0.00% |
| May 31, 2025 |
0.00% |
| Feb 28, 2025 |
-3.98% |
| Nov 30, 2024 |
115.72% |
| Aug 31, 2024 |
0.00% |
| May 31, 2024 |
-42.07% |
| Feb 29, 2024 |
-0.99% |
| Nov 30, 2023 |
376.42% |
| Aug 31, 2023 |
-52.68% |
| May 31, 2023 |
-43.24% |
| Feb 28, 2023 |
39.68% |
| Nov 30, 2022 |
17.22% |
| Aug 31, 2022 |
-13.79% |
| May 31, 2022 |
234.18% |
| Feb 28, 2022 |
191.97% |
| Nov 30, 2021 |
-22.42% |
| Aug 31, 2021 |
-92.56% |
| May 31, 2021 |
-10.76% |
| Feb 28, 2021 |
-30.17% |
| Nov 30, 2020 |
354.28% |
